Heme and lipid peroxides in hemoglobin-modified low-density lipoprotein mediate cell survival and adaptation to oxidative stress

Blood

Volumn 102, Issue 5, 2003, Pages 1732-1739

  Asatryan, Liana ^b   Ziouzenkova, Ouliana ^b   Duncan, Roger ^b   Sevanian, Alex ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; EBSELEN; HEME; HEME OXYGENASE 1; HEMIN; HEMOGLOBIN; HEMOGLOBIN MODIFIED LOW DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIDE; PROTOPORPHYRIN TIN; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CATALYST; CELL SURVIVAL; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INACTIVATION; ENZYME INDUCTION; LIPID OXIDATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; RABBIT;

EID: 0042442081     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0293     Document Type: Article

References (51)

1. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
2. Ehrenwald E, Fox PL. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest. 1996; 97:884-890.
3. Miller YI, Smith A, Morgan WT, Shaklai N. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry. 1996;35:13112-13117.
4. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997;17:1859-1867.
5. Gronholdt ML. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol. 1999;19:2-13.
6. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg. 2001;88:945-950.
7. Ziouzenkova O, Asatryan L, Akmal M, et al. Oxidative cross-linking of apoB100 and hemoglobin results in low density lipoprotein modification in blood: relevance to atherogenesis caused by hemodialysis. J Biol Chem. 1999;274:18916-18924.
8. Kuhn H, Gotze R, Schewe T, Rapoport SM. Quasi-lipoxygenase activity of haemoglobin: a model for lipoxygenases. Eur J Biochem. 1981; 120:161-168.
9. Cazzolato G, Avogaro P, Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med. 1991;11:247-253.
10. Miller YI, Shaklai N. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. Biochem Mol Biol Int. 1994;34:1121-1129.
11. Miller YI, Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta. 1999;1454:153-164.
12. Camejo G, Halberg C, Manschik-Lundin A, et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res. 1998;39:755-766.
13. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity: heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med. 2000;28:289-309.
14. Ramos P, Gieseg SP, Schuster B, Esterbauer H. Effect of temperature and phase transition on oxidative resistance of low density lipoprotein. J Lipid Res. 1995;36:2113-2128.
15. -). J Lipid Res. 1994;35:669-677.
16. Hodis HN, Crawford DW, Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 1991;89:117-126.
17. Chang YH, Abdalla DS, Sevanian A. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein. Free Radic Biol Med. 1997;23:202-214.
18. Quehenberger O, Jurgens G, Zadravec S, Esterbauer H. Oxidation of human low density lipoprotein initiated by copper (11) chloride. Basic Life Sci. 1988;49:387-390.
19. Muller A, Cadenas E, Graf P, Sies H. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem Pharmacol. 1984;33:3235-3239.
20. Auerbach BJ, Kiely JS, Cornicelli JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem. 1992;201:375-380.
21. Lutton JD, da Silva JL, Moqattash S, Brown AC, Levere RD, Abraham NG. Differential induction of heme oxygenase in the hepatocarcinoma cell line (Hep3B) by environmental agents. J Cell Biochem. 1992;49:259-265.
22. Turcanu V, Dhouib M, Poindron P. Determination of heme oxygenase activity in murine macrophages for studying oxidative stress inhibitors. Anal Biochem. 1998;263:251-253.
23. Pacifici EH, McLeod LL, Peterson H, Sevanian A. Linoleic acid hydroperoxide-induced peroxidation of endothelial cell phospholipids and cytotoxicity. Free Radic Biol Med. 1994;17:285-295.
24. 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture. Am J Pathol. 1985;121:200-211.
25. Ziouzenkova O, Sevanian A, Abuja PM, Ramos P, Esterbauer H. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic Biol Med. 1998;24:606-623.
26. Retsky KL, Chen K, Zeind J, Frei B. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med. 1999;26:90-98.
27. Sevanian A, Hwang J, Hodis HN, Cazzolato G, Avogaro P, Bittolo-Bon G. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb. 1996;16:784-793.
28. Schwartsburd PM. Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism. Cell Stress Chaperones. 2001;6:1-5.
29. Steinberg D, Carew TE, Fielding C, et al. Lipoproteins and the pathogenesis of atherosclerosis. Circulation. 1989;80:719-723.
30. Balla J, Jacob HS, Balla G, Nath K, Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction by heme proteins: a possible mechanism limiting shock damage. Trans Assoc Am Physicians. 1992;105:1-6.
31. Vile GF, Basu-Modak S, Waltner C, Tyrrell RM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A. 1994;91:2607-2610.
32. Juckett M, Zheng Y, Yuan H, et al. Heme and the endothelium: effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J Biol Chem. 1998;273:23388-23397.
33. Galaris D, Sevanian A, Cadenas E, Hochstein P. Ferrylmyoglobin-catalyzed linoleic acid peroxidation. Arch Biochem Biophys. 1990;281:163-169.
34. Hover CG, Kulkarni AP. A simple and efficient method for hemoglobin removal from mammalian tissue cytosol by zinc sulfate and its application to the study of lipoxygenase. Prostaglandins Leukot Essent Fatty Acids. 2000;62:97-105.
35. Kim E, Sevanian A. Hematin and peroxide catalyzed peroxidation of phospholipid liposomes. Arch Biochem Biophys. 1991;288:324-330.
36. Avogaro P, Bittolo-Bon G, Cazzolato G. Presence of modified low density lipoprotein in humans. Arteriosclerosis. 1998;8:79-87.
37. Dominaitiene R, Lindgren S, Janciauskiene S. Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro. In Vitro Mol Toxicol. 2001;14:83-97.
38. Matsunaga T, Nakajima T, Sonoda M, et al. Modulation of reactive oxygen species in endothelial cells by peroxynitrite-treated lipoproteins. J Biochem (Tokyo). 2001;130:285-293.
39. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta. 2002;1585:213-221.
40. Sevanian A, Hodis HN, Hwang J, McLeod LL, Peterson H. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J Lipid Res. 1995;36:1971-1986.
41. Colles SM, Irwin KC, Chisolm GM. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J Lipid Res. 1996;37:2018-2028.
42. Sevanian A, Shen L, Ursini F. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists. Pharmacol Res. 2000;8:999-1006.
43. Jeney V, Balla J, Yachie A, et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002; 100:879-887.
44. Stocker R, Yamamoto Y, McDonagh AF, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1045.
45. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995;96:2676-2682.
46. Piantadosi CA, Biological chemistry of carbon monoxide. Antioxid Redox Signal. 2002;4:259-270.
47. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129-135.
48. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94:10925-10930.
49. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 1997;100:1209-1216.
50. Agarwal A, Shiraishi F, Visner GA, Nick HS. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol. 1998;9:1990-1997.
51. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Ex. pression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol. 1998;152:711-720.